The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Chromobacterium violaceum: A Review of Pharmacological and Industiral Perspectives
Open accessAbstract
Violet-pigmented bacteria, which have been described since the end of the 19th century, are occasionally the causative agent of septicemia and sometimes cause fatal infection in human and animals. Bacteria, producing violet colonies due to the production of a nondiffusible pigment violacein, were classified as a redefined genus Chromobacterium. Chromobacterium violaceum is gram-negative, and saprophyte from soil and water is normally considered nonpathogenic to human, but is an opportunistic pathogen of extreme virulence for human and animals. The biosynthesis and biological activities of violacein and the diverse effects of this pigment have been studied. Besides violacein, C. violaceum produces other antibiotics, such as aerocyanidin and aerocavin, which exhibit in vitro activity against both gram-negative and gram-positive bacteria. 3,6-Dihydroxyindoxazene and Y-TO678h exhibit a selective activity against gram-negative bacteria. Arphamenine A and B, and FR901228, that enhanced immunoresponse, and potentiators of beta-lactam antibiotics and chelators such as ferrioxamine exhibit important clinical potential applications. Lipopolysaccharides and polyhydroxyesters together with several enzymes appear as important metabolites with biotechnological applications. Many of these metabolites were already studied at the genome level.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McClean, K. H., Winson, M. K., Fish, L., Taylor, A., Chhabra, S. R., Camara, M., Daykin, M., Lamb, J. H., Swift, S., Bycroft, B. W., et al. (1997) · Microbiology · doi:10.1099/00221287-143-12-3703 · Cited by 1,744
Cha, C., Gao, P., Chen, Y.-C., Shaw, P. D., & Farrand, S. K. (1998) · Molecular Plant-Microbe Interactions® · doi:10.1094/mpmi.1998.11.11.1119 · Cited by 618
UEDA, H., NAKAJIMA, H., HORI, Y., FUJITA, T., NISHIMURA, M., GOTO, T., & OKUHARA, M. (1994) · The Journal of Antibiotics · doi:10.7164/antibiotics.47.301 · Cited by 489
FR901228, a Potent Antitumor Antibiotic, Is a Novel Histone Deacetylase Inhibitor
Nakajima, H., Kim, Y. B., Terano, H., Yoshida, M., & Horinouchi, S. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4027 · Cited by 487
Sandor, V, Senderowicz, A., Mertins, S., Sackett, D., Sausville, E., Blagosklonny, M. V., & Bates, S. E. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1327 · Cited by 290
Chernin, L. S., Winson, M. K., Thompson, J. M., Haran, S., Bycroft, B. W., Chet, I., Williams, P., & Stewart, G. S. A. B. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.17.4435-4441.1998 · Cited by 238
Blosser, R. S., & Gray, K. M. (2000) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(99)00136-0 · Cited by 237
Total Synthesis of the Antitumor Depsipeptide FR-901,228
Li, K. W., Wu, J. J., Xing, W., & Simon, J. A. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9613724 · Cited by 167
Byrd, J. C., Shinn, C. A., Ravi, R. K., Willis, C. R., Waselenko, J. K., Flinn, I. W., Dawson, N. A., & Grever, M. R. (1999) · Blood · doi:10.1182/blood.v94.4.1401 · Cited by 156
Ueda, H., Nakajima, H., Hori, Y., Goto, T., & OKUHARA, M. (1994) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.58.1579 · Cited by 144
August, P. R., Grossman, T. H., Minor, C., Draper, M. P., MacNeil, I. A., Pemberton, J., Call, K. M., Holt, D., & Osburne, M. S. (2000) · PubMed · Cited by 143
Shigematsu, N., Ueda, H., Takase, S., Tanaka, H., Yamamoto, K., & TADA, T. (1994) · The Journal of Antibiotics · doi:10.7164/antibiotics.47.311 · Cited by 134
Macher, A. M., Casale, T. B., & Fauci, A. S. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-1-51 · Cited by 121
Bradley, E. L. (1994) · Springer eBooks · doi:10.1007/978-3-642-79167-3_1 · Cited by 120
Synthesis and production of poly(3-hydroxyvaleric acid) homopolyester by Chromobacterium violaceum
Steinb�chel, A., Debzi, E.-M., MARCHESSAULT, R. H., & Timm, A. (1993) · Applied Microbiology and Biotechnology · doi:10.1007/bf00205030 · Cited by 118
Christian, M. C., Pluda, J. M., Ho, P. T. C., Arbuck, S. G., Murgo, A. J., & Sausville, E. A. (1997) · PubMed · Cited by 57
FR901228 causes mitotic arrest but does not alter microtubule polymerization
Sandor, V. A., ROBBINS, A. R., Robey, R. W., Myers, T. G., Sausville, E. A., Bates, S. E., & Sackett, D. L. (2000) · Anti-Cancer Drugs · doi:10.1097/00001813-200007000-00005 · Cited by 47
SQ 26,180, a novel monobactam. I. Taxonomy, fermentation and biological properties.
WELLS, J. S., TREJO, W. H., Principe, P. A., Bush, K., Georgopapadakou, N. H., BONNER, D. P., & SYKES, R. B. (1982) · The Journal of Antibiotics · doi:10.7164/antibiotics.35.184 · Cited by 45
Isolation and Identification of Poly(3-Hydroxyvalerate)-Degrading Strains of Pseudomonas lemoignei
Mergaert, J., Schirmer, A., Hauben, L., Mau, M., Hoste, B., Kersters, K., Jendrossek, D., & Swings, J. (1996) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-46-3-769 · Cited by 44
Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells
Murata, M., Towatari, M., Kosugi, H., Tanimoto, M., Ueda, R., Saito, H., & Naoe, T. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00899.x · Cited by 41
Copper in biological systems. A report from the 6th Manziana conference, September 23–27, 1990
Beinert, H. (1991) · Journal of Inorganic Biochemistry · doi:10.1016/0162-0134(91)80054-l · Cited by 39
Phenylalanine Hydroxylase from Chromobacterium violaceum
Chen, D., & Frey, P. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25594 · Cited by 39
Steinbüchel, A., & Schmack, G. (1995) · Journal of Polymers and the Environment · doi:10.1007/bf02068679 · Cited by 38
Quorum sensing autoinducers: Do they play a role in natural microbial habitats?
Bachofen, R., & Schenk, A. (1998) · Microbiological Research · doi:10.1016/s0944-5013(98)80022-0 · Cited by 36
Violacein transformation by peroxidases and oxidases: implications on its biological properties
Bromberg, N., & Durán, N. (2001) · Journal of Molecular Catalysis B Enzymatic · doi:10.1016/s1381-1177(00)00171-5 · Cited by 33
Self-citationNovel therapies for chronic lymphocytic leukemia in the 21st century.
Byrd, J. C., Waselenko, J. K., Keating, M., Rai, K., & Grever, M. R. (2000) · PubMed · Cited by 33
Effect of growth conditions on production of violacein by Chromobacterium violaceum (BB-78 strain).
Maidana, R. L. B. R., Haun, M., & Durán, N. (1989) · PubMed · Cited by 28
Self-citationThe Tryptophan Hydroxylase of Chromobacterium violaceum
Letendre, C. H., Dickens, G., & Guroff, G. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42091-7 · Cited by 25
Yu, T.-S., & Kim, T. H. (1999) · Journal of Microbiology and Biotechnology · Cited by 2
Cited by
Durán, N., Marcato, P. D., De Souza, G. I. H., Alves, O. L., & Esposito, E. (2007) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2007.022 · Cited by 971
Self-citationInhibition of bacterial quorum sensing by vanilla extract
Choo, J. H., Rukayadi, Y., & Hwang, J.-K. (2006) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2006.01928.x · Cited by 439
Indolocarbazole natural products: occurrence, biosynthesis, and biological activity
Sánchez, C., Méndez, C., & Salas, J. A. (2006) · Nat. Prod. Rep. · doi:10.1039/b601930g · Cited by 407
Color me bad: microbial pigments as virulence factors
Liu, G. Y., & Nizet, V. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2009.06.006 · Cited by 378
Brucker, R. M., Harris, R. N., Schwantes, C. R., Gallaher, T. N., Flaherty, D. C., Lam, B. A., & Minbiole, K. P. C. (2008) · Journal of Chemical Ecology · doi:10.1007/s10886-008-9555-7 · Cited by 355
Metadata
- Authors
- Durán, N., & Menck, C. F. M.
- Venue
- Critical Reviews in Microbiology
- Publisher
- Informa UK Limited
- Published
- 2001-01
- Volume
- 27
- Issue
- 3
- Pages
- 201-222
- ISSN
- 1040-841X (ISSN-L)
- 1549-7828
- OpenAlex
- W2152277794
- Cited by
- 273
- References
- 29
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.